PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel (Q27853112)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel |
scientific article |
Statements
February 2015
0 references
51
0 references
3
0 references
359-66
0 references